Cargando…
Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study
Fenofibrate lowers triglycerides (TG) and raises high density lipoprotein cholesterol (HDLc) in dyslipidemic individuals. Several studies have shown genetic variability in lipid responses to fenofibrate treatment. It is, however, not known whether epigenetic patterns are also correlated with the cha...
Autores principales: | Das, Mithun, Irvin, M. Ryan, Sha, Jin, Aslibekyan, Stella, Hidalgo, Bertha, Perry, Rodney T., Zhi, Degui, Tiwari, Hemant K., Absher, Devin, Ordovas, Jose M., Arnett, Donna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586504/ https://www.ncbi.nlm.nih.gov/pubmed/26483836 http://dx.doi.org/10.3389/fgene.2015.00304 |
Ejemplares similares
-
Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study
por: Irvin, Marguerite R., et al.
Publicado: (2018) -
Genomics of Post-Prandial Lipidomic Phenotypes in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
por: Irvin, Marguerite R., et al.
Publicado: (2014) -
Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
por: Das, Mithun, et al.
Publicado: (2016) -
Epigenome-Wide Association Study of Fasting Measures of Glucose, Insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network Study
por: Hidalgo, Bertha, et al.
Publicado: (2014) -
An Exome-Wide Sequencing Study of the GOLDN Cohort Reveals Novel Associations of Coding Variants and Fasting Plasma Lipids
por: Geng, Xin, et al.
Publicado: (2019)